US court rehears GSK challenge to patent prosecution rules
This article was originally published in Scrip
Executive Summary
A US appeals court has granted GlaxoSmithKline's request to reconsider its March ruling upholding patent prosecution rules opposed by the pharmaceutical and biotechnology industries. The rules would impose new limits and evidentiary requirements on continued examinations and claim filings.